These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1647246)

  • 1. A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes.
    Gozes Y; Brenneman DE; Fridkin M; Asofsky R; Gozes I
    Brain Res; 1991 Feb; 540(1-2):319-21. PubMed ID: 1647246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
    Gozes I; McCune SK; Jacobson L; Warren D; Moody TW; Fridkin M; Brenneman DE
    J Pharmacol Exp Ther; 1991 Jun; 257(3):959-66. PubMed ID: 1646331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of sulfhydryl groups in the binding of vasoactive intestinal peptide to its receptor on murine lymphocytes.
    Ottaway CA
    J Neuroimmunol; 1992 Jul; 39(1-2):49-56. PubMed ID: 1320058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.
    Chakder S; Rattan S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):392-9. PubMed ID: 8392560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.
    Moody TW; Zia F; Draoui M; Brenneman DE; Fridkin M; Davidson A; Gozes I
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4345-9. PubMed ID: 8389448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29.
    Turner JT; Jones SB; Bylund DB
    Peptides; 1986; 7(5):849-54. PubMed ID: 3025826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors for vasoactive intestinal peptide on murine lymphocytes turn over rapidly.
    Ottaway CA
    J Neuroimmunol; 1992 Jun; 38(3):241-53. PubMed ID: 1318321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertion and internalization of vasoactive intestinal peptide (VIP) receptors in murine CD4 T lymphocytes.
    Ottaway CA
    Regul Pept; 1992 Sep; 41(1):49-59. PubMed ID: 1360688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of a bovine thymic peptide extract with vasoactive intestinal peptide (VIP) receptors.
    Guerrero JM; Goberna R; Molinero P; Jimenez J; Calvo JR
    Biosci Rep; 1986 Jun; 6(6):579-84. PubMed ID: 3021253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [125I]vasoactive intestinal polypeptide binding sites: quantitative autoradiographic distribution in the rat spinal cord.
    Yashpal K; Sarrieau A; Quirion R
    J Chem Neuroanat; 1991; 4(6):439-46. PubMed ID: 1664212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide.
    Rorstad OP; Wanke I; Coy DH; Fournier A; Huang M
    Mol Pharmacol; 1990 Jun; 37(6):971-7. PubMed ID: 2163020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and expression of the human vasoactive intestinal peptide receptor.
    Sreedharan SP; Robichon A; Peterson KE; Goetzl EJ
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4986-90. PubMed ID: 1675791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prepro-vasoactive intestinal peptide-derived peptides on the murine immune response.
    Yiangou Y; Serrano R; Bloom SR; Peña J; Festenstein H
    J Neuroimmunol; 1990; 29(1-3):65-72. PubMed ID: 2170441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle.
    Guijarro LG; Rodriguez-Pena MS; Prieto JC
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin downregulates receptors for vasoactive intestinal peptide and secretin in rat pancreatic acini.
    Katsushima S; Adachi H; Honda T; Sato S; Kusui T; Onishi S; Aoki E; Noguchi M; Konishi J
    Am J Physiol; 1990 Mar; 258(3 Pt 1):G395-403. PubMed ID: 2156442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
    Mittag TW; Tormay A; Podos SM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lindane effect upon the vasoactive intestinal peptide receptor/effector system in rat enterocytes.
    Carrero I; Fernández-Moreno MD; Pérez-Albarsanz MA; Prieto JC
    Biochem Biophys Res Commun; 1989 Mar; 159(3):1391-6. PubMed ID: 2467674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PACAP and VIP receptors in rat liver membranes.
    Robberecht P; Gourlet P; Cauvin A; Buscail L; De Neef P; Arimura A; Christophe J
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G97-102. PubMed ID: 1846275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes.
    Gourlet P; De Neef P; Woussen-Colle MC; Vandermeers A; Vandermeers-Piret MC; Robberecht P; Christophe J
    Biochim Biophys Acta; 1991 Jul; 1066(2):245-51. PubMed ID: 1649637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.